Stockholm - Delayed Quote SEK

BioArctic AB (publ) (BIOA-B.ST)

Compare
206.80
+2.20
+(1.08%)
At close: January 10 at 5:29:42 PM GMT+1
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
167,141.00
615,995.00
228,291.00
23,146.00
62,347.00
Cost of Revenue
90,504.00
89,627.00
74,326.00
55,067.00
50,242.00
Gross Profit
76,637.00
526,368.00
153,965.00
-31,921.00
12,105.00
Operating Expense
325,422.00
269,409.00
161,903.00
107,932.00
94,423.00
Operating Income
-248,785.00
256,959.00
-7,938.00
-139,853.00
-82,318.00
Net Non Operating Interest Income Expense
41,839.00
33,849.00
1,785.00
-983.00
-1,091.00
Pretax Income
-221,269.00
276,485.00
-11,167.00
-140,511.00
-86,691.00
Tax Provision
11,593.00
47,237.00
11.00
-20,723.00
-18,174.00
Net Income Common Stockholders
-232,861.00
229,249.00
-11,179.00
-119,789.00
-68,517.00
Diluted NI Available to Com Stockholders
-232,861.00
229,249.00
-11,179.00
-119,789.00
-68,517.00
Basic EPS
-2.64
2.60
-0.13
-1.36
-0.78
Diluted EPS
-2.64
2.59
-0.13
-1.36
-0.78
Basic Average Shares
88,301.14
88,230.64
88,074.30
88,059.99
88,059.99
Diluted Average Shares
88,373.21
88,487.40
88,682.99
88,579.99
88,181.99
Total Operating Income as Reported
-253,103.00
252,640.00
-17,336.00
-139,723.00
-85,012.00
Total Expenses
415,926.00
359,036.00
236,229.00
162,999.00
144,665.00
Net Income from Continuing & Discontinued Operation
-232,861.00
229,249.00
-11,179.00
-119,789.00
-68,517.00
Normalized Income
-232,861.00
229,249.00
-11,179.00
-119,782.18
-68,351.89
Interest Income
41,539.00
34,228.00
2,535.00
--
7.00
Interest Expense
-351.00
328.00
559.00
838.00
984.00
Net Interest Income
41,839.00
33,849.00
1,785.00
-983.00
-1,091.00
EBIT
-221,620.00
276,813.00
-10,608.00
-139,673.00
-85,707.00
EBITDA
-221,620.00
295,241.00
4,025.00
-126,566.00
-74,694.00
Reconciled Cost of Revenue
90,504.00
89,627.00
74,326.00
55,067.00
50,242.00
Reconciled Depreciation
--
7,439.00
14,184.00
13,045.00
10,920.00
Net Income from Continuing Operation Net Minority Interest
-232,861.00
229,249.00
-11,179.00
-119,789.00
-68,517.00
Total Unusual Items Excluding Goodwill
--
--
--
-8.00
-209.00
Total Unusual Items
--
--
--
-8.00
-209.00
Normalized EBITDA
-221,620.00
295,241.00
4,025.00
-126,558.00
-74,485.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
--
-1.18
-43.89
12/31/2020 - 10/12/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ISOFOL.ST Isofol Medical AB (publ)
2.3600
-3.28%
 
ALZ.ST Alzinova AB (publ)
3.2800
-2.38%
 
PHVS Pharvaris N.V.
17.80
-3.99%
 
ABVX ABIVAX Société Anonyme
6.38
-4.49%
 
GEM.F GeNeuro SA
0.1400
+7.69%
 
64Z.F Keymed Biosciences Inc.
3.3400
-2.91%
 
CYXO.ST Cyxone AB (publ)
0.0180
0.00%
 
ELIC-TO2.ST Elicera Therapeutics AB
0.3400
0.00%
 
INCPF InnoCare Pharma Limited
3.2600
0.00%
 
MAGLE.ST Magle Chemoswed Holding AB (publ)
37.40
0.00%